Schmidt, Sebastian https://orcid.org/0000-0003-4408-6697
Stautner, Constantin
Vu, Duc Tung https://orcid.org/0000-0002-7573-1591
Heinz, Alexander
Regensburger, Martin https://orcid.org/0000-0002-2172-7386
Karayel, Ozge https://orcid.org/0000-0003-2541-1159
Trümbach, Dietrich https://orcid.org/0000-0001-9027-3704
Artati, Anna
Kaltenhäuser, Sabine
Nassef, Mohamed Zakaria
Hembach, Sina
Steinert, Letyfee
Winner, Beate
Jürgen, Winkler https://orcid.org/0000-0003-0630-9204
Jastroch, Martin https://orcid.org/0000-0003-0358-3865
Luecken, Malte D. https://orcid.org/0000-0001-7464-7921
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Westmeyer, Gil Gregor
Adamski, Jerzy https://orcid.org/0000-0001-9259-0199
Mann, Matthias https://orcid.org/0000-0003-1292-4799
Hiller, Karsten https://orcid.org/0000-0001-9322-5820
Giesert, Florian https://orcid.org/0000-0001-6825-8858
Vogt Weisenhorn, Daniela M. https://orcid.org/0000-0002-4566-6506
Wurst, Wolfgang https://orcid.org/0000-0003-4422-7410
Article History
Received: 14 February 2023
Accepted: 23 October 2023
First Online: 23 November 2023
Competing interests
: F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd, and Omniscope Ltd, and has ownership interest in Dermagnostix GmbH and Cellarity. The remaining authors declare no competing interests.